We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Management of Takayasu arteritis

    Gulten Tacoy

    *Author for correspondence: Tel.: +90 312 202 5633; +90 532 355 4903; Fax: +90 312 212 9012;

    E-mail Address: gtacoy@gmail.com

    Professor in Cardiology, Cardiology Department, Faculty of Medicine, Gazi University, Beşevler, Ankara, Turkey

    Published Online:https://doi.org/10.2217/fca-2017-0030
    Free first page

    References

    • 1 Takayasu M. A case with peculiar changes of the retinal central vessels (in Japanese). Acta Soc. Ophthal. Jpn. 12, 554–555 (1908).
    • 2 Al-Bishri J. Takayasu's arteritis: a review article. Br. J. Med. Med. Res. 3, 811–820 (2013).
    • 3 Vidhate M, Garg RK, Yadav R, Kohli N, Naphade P, Anuradha HK. An unusual case of Takayasu's arteritis. Evaluation of by CT angiography. Ann. Indian Acad. Neurol. 14(4), 304–306 (2011).
    • 4 Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J. Clin. Pathol. 55(7), 481–486 (2002).
    • 5 Taçoy G, Akyel A, Tavil Y, Çengel A. Patient with Takayasu arteritis presented as cardiogenic shock. Future Cardiol. 6(6), 889–93 (2010).
    • 6 Tann OR, Tulloh RMR, Hamilton MCK. Takayasu's disease: a review. Cardiol. Young 18(3), 250–259 (2008).
    • 7 Alibaz-Öner F, Aydın SZ, Direskeneli H. Recent advances in Takayasu's arteritis. Eur. J. Rheum. 2(1), 24–30 (2015).
    • 8 Lee GY, Jang SY, Ko SM et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int. J. Cardiol. 159(1), 14–20 (2012).
    • 9 Sharma S, Rajani M, Talwar KK. Angiographic morphology in nonspecific aortoarteritis (Takayasu's arteritis): a study of 126 patients from North India. Cardiovasc. Intervent. Radiol. 15(3), 160–165 (1992).
    • 10 Paul JF, Hernigou A, Lefebvre C et al. Electron beam CT features of the pulmonary artery in Takayasu's arteritis. AJR Am. J. Roentgenol. 173(1), 89–93 (1999).
    • 11 Assad AP, da Silva TF, Bonfa E, Pereira RM. Maternal and neonatal outcomes in 89 patients with Takayasu arteritis (TA): comparison before and after the TA diagnosis. J. Rheumatol. 42(10), 1861–1864 (2015).
    • 12 Alpay-Kanitez N, Omma A, Erer B et al. Favourable pregnancy outcome in Takayasu arteritis: a single-center experience. Clin. Exp. Rheumatol. 33(Suppl. 89), S7–S10 (2015).
    • 13 Misra R, Danda D, Rajappa SM et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 52(10), 1795–1801 (2013).
    • 14 Seyahi E. Takayasu arteritis: an update. Curr. Opin. 29, 51–56 (2017).
    • 15 Lim AY, Lee GY, Jang ST et al. Gender differences in clinical and angiographic findings of patients with Takayasu arteritis. Clin. Exp. Rheumatol. 33(Suppl. 89), S132–S137 (2015).
    • 16 Arend WP, Micheel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arteritis Rheum. 33(8), 1129–1134 (1990).
    • 17 Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 57, 27–35 (1978).
    • 18 Numano F. Differences in clinical presentation and outcome in different countries for Takayasu's arteritis. Curr. Opin. Rheumatol. 9(1), 12–15 (1997).
    • 19 Kato Y, Terashima M, Ohigashi H et al. Vessel wall inflammation of Takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: association with disease distribution and activity. PLoS ONE 10(12), e0145855 (2015).
    • 20 Chrapko BE, Chrapko M, Nocun A et al. Role of 18F-FDG PET/CT in the diagnosis of inflammatory and infectious vascular disease. Nucl. Med. Rev. Cent. East Eur. 19(1), 28–36 (2016).
    • 21 Pipitone N, Pazzola G, Muratore F et al. Assessment of vasculitis extent and severity. Presse Med. 42(4Pt2), 588–589 (2013).
    • 22 Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 56(3), 1000–1009 (2007).
    • 23 Saruhan Direskeneli G, Hughes T, Aksu K et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am. J. Hum. Genet. 93(2), 298–305 (2013).
    • 24 Park MC, Lee SW, Park YB et al. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford) 45(5), 545–548 (2006).
    • 25 Clifford A, Hoffman GS. Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies. Curr. Opin. Rheumatol. 26(1), 7–15 (2014).
    • 26 De Souza AW, de Almeida Agustinelli R, de Cinque Almeida H et al. Leflunomide in Takayasu arteritis – a long term observational study. Rev. Bras. Rheulatol. Engl. Ed. 56, 371–375 (2016).
    • 27 Loricera J, Blanco R, Hernandez JL et al. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review. Clin. Exp. Rheumatol. 34(Suppl. 97), 44–53 (2016).
    • 28 Batu ED, Sönmez HE, Hazırolan T et al. Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature. Semin. Arthritis Rheum. 46(4), 529–535 (2017).
    • 29 Saadoun D, Lambert M, Mirault T et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation 125(6), 813–819 (2012).
    • 30 Kim YW, Kim DI, Park YJ et al. Surgical bypass vs endovascular treatment for patients with supra-aortic arteria occlusive disease due to Takayasu arteritis. J. Vasc. Surg. 55(3), 693–700 (2012).
    • 31 Visona A, Tonello D, Zalunardo B et al. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus. 7(1), 18–23 (2009).